As such, PD-L1 could play a crucial role in the immune microenvironment between the primary tumor and the secondary metastatic tumor; PD-L1 can help increase the understanding of cancer’s response to immunotherapy and develop PD-L-targeted therapy [29]. The gene discussed is CD274; the disease is cancer.